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The first national plan for rare diseases (2005-2008) set
the network for care and research in the rare diseases
(RD) field across all French hospitals. The 131 RD centers
of expertise (CE) initiated then various IT projects to
register electronically their RD patients. The CEMARA
project [1] up to now registered 235,000 RD patients, from
62 RDCE (out of 131), 383 units of care and described
over 4000 rare diseases. The identified limits of the
CEMARA model were: i) data collection was not incorpo-
rated in the care setting, ii) exposed to data re-entry,
iii) coping with data privacy new regulations and iv) gain-
ing a wide national consensus on the data to collect for all
RDs and from all CEs. To overcome these limits, the 2nd
national plan for rare diseases (2010-2014) promoted the
creation of a national data repository for all rare diseases
(BNDMR) based on the CEMARA model with the follow-
ing objectives: i) identifying RD patients within the health
information systems in care setting, ii) describing the RD
demand of care, and the adequacy of the supply and
iii) identifying patients eligible for clinical trials or cohorts.
The proposed national architecture incorporates a
national minimum data set for all rare diseases (F-MDS-
RD) into hospital information care systems to enable elec-
tronic patient files re-use for epidemiological studies or
research [2]. To ensure a full interoperability between
local hospital information systems and the BNDMR, a
national interoperability framework is defined. It is set on
3 pillars: i) defining a national patient ID for rare diseases
that will help to identify patients across different health IS,
ii) defining a common data format for all rare diseases,
compatible with EHR standards such as HL7, and iii)
setting the necessary technical data flows complying with
strict security rules for data privacy [3] and security.
The minimum data set for rare diseases is now being
implemented in several local systems, and connectors are
being rolled out with several database suppliers. Data
re-entry is nowadays a major concern for clinicians.
Enabling data re-use is not only an interoperability
problem; data must be structured, qualified, standardized
[4] and suitable for research [5]. The structuration of the
data collected is set on a variety of standard terminologies
such as Orphanet or the Human Phenotype Ontology
which requires to be accompanied with the necessary IT
tools to help clinicians coding the data [6].
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